Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 760

1.

A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.

Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.

Phytomedicine. 2013 Nov 15;20(14):1256-66. doi: 10.1016/j.phymed.2013.07.007. Epub 2013 Aug 6.

PMID:
23928508
2.

A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats.

Sharan K, Swarnkar G, Siddiqui JA, Kumar A, Rawat P, Kumar M, Nagar GK, Manickavasagam L, Singh SP, Mishra G, Wahajuddin, Jain GK, Maurya R, Chattopadhyay N.

Menopause. 2010 May-Jun;17(3):577-86. doi: 10.1097/gme.0b013e3181d2ce7f.

PMID:
20393370
3.

A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.

Sharan K, Mishra JS, Swarnkar G, Siddiqui JA, Khan K, Kumari R, Rawat P, Maurya R, Sanyal S, Chattopadhyay N.

J Bone Miner Res. 2011 Sep;26(9):2096-111. doi: 10.1002/jbmr.434.

4.

Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.

Xu D, Yang W, Zhou C, Liu Y, Xu B.

Planta Med. 2010 Nov;76(16):1809-13. doi: 10.1055/s-0030-1250040. Epub 2010 Jun 24.

PMID:
20577944
5.

Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.

Srivastava K, Tyagi AM, Khan K, Dixit M, Lahiri S, Kumar A, Changkija B, Khan MP, Nagar GK, Yadav DK, Maurya R, Singh SP, Jain GK, Wahajuddin, Trivedi R, Chattopadhyay N, Singh D.

Phytomedicine. 2013 Apr 15;20(6):470-80. doi: 10.1016/j.phymed.2012.12.021. Epub 2013 Feb 8.

PMID:
23395215
6.

A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.

Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.

Bone. 2014 Jan;58:151-9. doi: 10.1016/j.bone.2013.10.005. Epub 2013 Oct 11.

PMID:
24125756
7.

A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone.

Siddiqui JA, Swarnkar G, Sharan K, Chakravarti B, Gautam AK, Rawat P, Kumar M, Gupta V, Manickavasagam L, Dwivedi AK, Maurya R, Chattopadhyay N.

Osteoporos Int. 2011 Dec;22(12):3013-27. doi: 10.1007/s00198-010-1519-4. Epub 2011 Jan 12.

PMID:
21225417
8.

Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.

Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.

J Bone Miner Res. 2007 Jun;22(6):849-59.

9.

Bone quality and strength are greater in growing male rats fed fructose compared with glucose.

Bass EF, Baile CA, Lewis RD, Giraudo SQ.

Nutr Res. 2013 Dec;33(12):1063-71. doi: 10.1016/j.nutres.2013.08.006. Epub 2013 Oct 9.

PMID:
24267046
10.

Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.

Shen CL, Zhu W, Gao W, Wang S, Chen L, Chyu MC.

Nutr Res. 2013 Aug;33(8):668-76. doi: 10.1016/j.nutres.2013.05.008. Epub 2013 Jun 24.

PMID:
23890357
11.

Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.

Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V.

J Bone Miner Res. 1996 Apr;11(4):421-9.

PMID:
8992872
12.

Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect.

Sharan K, Siddiqui JA, Swarnkar G, Tyagi AM, Kumar A, Rawat P, Kumar M, Nagar GK, Arya KR, Manickavasagam L, Jain GK, Maurya R, Chattopadhyay N.

Menopause. 2010 Mar;17(2):393-402. doi: 10.1097/gme.0b013e3181bfae38.

PMID:
20009959
13.

Quercetin-6-C-β-D-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats.

Siddiqui JA, Sharan K, Swarnkar G, Rawat P, Kumar M, Manickavasagam L, Maurya R, Pierroz D, Chattopadhyay N.

Menopause. 2011 Feb;18(2):198-207. doi: 10.1097/gme.0b013e3181e84e67.

PMID:
20671576
14.

The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.

Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT.

Bone. 2006 Aug;39(2):244-52. Epub 2006 Feb 28.

PMID:
16503210
15.

[Dynamic effects of glucocorticoid on bone mineral density and microarchitecture: experiment with rats].

Liu SP, Chen J, Yang SM, Wu XP, Liao EY, Sheng ZF, Mo H, Ma YL, Zhang YH, Liu W, Jin Y, Dai RC.

Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2281-4. Chinese.

PMID:
19087680
16.

Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.

Wang FS, Ko JY, Yeh DW, Ke HC, Wu HL.

Endocrinology. 2008 Apr;149(4):1793-801. doi: 10.1210/en.2007-0910. Epub 2008 Jan 3.

PMID:
18174290
17.

Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.

Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.

Calcif Tissue Int. 2006 Oct;79(4):262-72. Epub 2006 Sep 11.

PMID:
16969596
18.

Emodin enhances osteogenesis and inhibits adipogenesis.

Yang F, Yuan PW, Hao YQ, Lu ZM.

BMC Complement Altern Med. 2014 Feb 24;14:74. doi: 10.1186/1472-6882-14-74.

19.

Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.

Wang FS, Ko JY, Weng LH, Yeh DW, Ke HJ, Wu SL.

Life Sci. 2009 Nov 4;85(19-20):685-92. doi: 10.1016/j.lfs.2009.09.009. Epub 2009 Sep 25.

PMID:
19782693
20.

Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

Weinstein RS, Jilka RL, Almeida M, Roberson PK, Manolagas SC.

Endocrinology. 2010 Jun;151(6):2641-9. doi: 10.1210/en.2009-1488. Epub 2010 Apr 21.

Supplemental Content

Support Center